Carmat SA
PAR:ALCAR
Carmat SA
PAR:ALCAR
Price:
0.099
EUR
Market Cap:
€6.4m
Relative Value
There is not enough data to reliably calculate the relative value of ALCAR.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ALCAR
Relative Value
Base Case
Not Available
Multiples Across Competitors
ALCAR Competitors Multiples
Carmat SA Competitors
Carmat SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
|
Carmat SA
PAR:ALCAR
|
6.4m EUR | 0.9 | -0.1 | -1.6 | -1.2 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
200.1B USD | 4.5 | 30.6 | 17.4 | 23.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
174.7B USD | 17.4 | 61.2 | 46.5 | 57.2 | |
| US |
|
Stryker Corp
NYSE:SYK
|
146.9B USD | 5.8 | 45.2 | 22.9 | 27.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
126.6B USD | 3.6 | 27.4 | 14.8 | 21.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.4B USD | 5.5 | 38.1 | 22.6 | 30.4 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46.9B EUR | 2 | 22.2 | 12.3 | 17.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
52.7B USD | 2.4 | 29.9 | 11.3 | 19.2 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
49.9B USD | 11.6 | 47 | 33.6 | 37.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48B USD | 7.9 | 44.7 | 24.8 | 27.1 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.3B USD | 1.9 | 18.4 | 13 | 15.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
